MedTrace Logo MedTrace
Clinical Trials News Drugs Diseases Companies About

Ornithine Transcarbamylase (OTC) Deficiency

  1. Home
  2. Diseases
  3. Ornithine Transcarbamylase (OTC) Deficiency
  4. Clinical Trials

Clinical Trials Related to Ornithine Transcarbamylase (OTC) Deficiency

Related studies linked through entity extraction aliases.

NCT03636438

Long Term Follow Up to Evaluate DTX301 in Adults With Late-Onset OTC Deficiency

Status
ACTIVE_NOT_RECRUITING
Phase
N/A

NCT02991144

Safety and Dose-Finding Study of DTX301 (scAAV8OTC) in Adults With Late-Onset Ornithine Transcarbamylase (OTC) Deficiency

Status
COMPLETED
Phase
PHASE1/PHASE2

Clinical Trials

Explore studies by the year of their last update.

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005

News & Analysis

Latest news and insights on clinical trials and medical research.

Browse All News →
MedTrace Logo MedTrace
About Privacy Policy Terms of Service Medical Disclaimer

© 2026 MedTrace.
Open-access medical & pharmaceutical data intelligence.